New Zealand markets closed

USANA Health Sciences, Inc. (USNA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
48.50+0.23 (+0.48%)
At close: 04:00PM EDT
48.50 0.00 (0.00%)
After hours: 05:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 928.74M
Enterprise value 606.38M
Trailing P/E 14.63
Forward P/E 17.54
PEG ratio (5-yr expected) 1.46
Price/sales (ttm)1.01
Price/book (mrq)1.87
Enterprise value/revenue 0.66
Enterprise value/EBITDA 4.93

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-22.74%
S&P500 52-week change 329.57%
52-week high 369.60
52-week low 344.01
50-day moving average 348.55
200-day moving average 354.63

Share statistics

Avg vol (3-month) 377.67k
Avg vol (10-day) 396.53k
Shares outstanding 519.24M
Implied shares outstanding 619.24M
Float 817.96M
% held by insiders 141.80%
% held by institutions 155.97%
Shares short (15 Mar 2024) 4255.09k
Short ratio (15 Mar 2024) 42.64
Short % of float (15 Mar 2024) 42.26%
Short % of shares outstanding (15 Mar 2024) 41.33%
Shares short (prior month 15 Feb 2024) 4162.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Nov 2016

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2023
Most-recent quarter (mrq)30 Dec 2023

Profitability

Profit margin 6.93%
Operating margin (ttm)10.95%

Management effectiveness

Return on assets (ttm)9.46%
Return on equity (ttm)13.69%

Income statement

Revenue (ttm)921.01M
Revenue per share (ttm)47.85
Quarterly revenue growth (yoy)-3.00%
Gross profit (ttm)N/A
EBITDA 105.77M
Net income avi to common (ttm)63.79M
Diluted EPS (ttm)3.30
Quarterly earnings growth (yoy)31.00%

Balance sheet

Total cash (mrq)330.42M
Total cash per share (mrq)17.17
Total debt (mrq)13.21M
Total debt/equity (mrq)2.66%
Current ratio (mrq)3.52
Book value per share (mrq)25.99

Cash flow statement

Operating cash flow (ttm)70.64M
Levered free cash flow (ttm)61.35M